Atwater Malick
GSK icon

Atwater Malick’s GSK GSK Stock Holding History

Atwater Malick’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$623K Buy
+12,925
New +$660K 0.14% 72
2019
Q4 		– Sell
-68
Closed -$4K – 104
2019
Q3 		$4K Buy
+68
New +$3.5K ﹤0.01% 184

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Atwater Malick's GSK Position: Q3 2026 in Review

Atwater Malick opened a new position in GSK (GSK) in Q3 2026: 12,925 shares worth $623K. The stake represents 0.14% of the portfolio and ranks #72 among its holdings. This is a return to the name: Atwater Malick previously reported a position in GSK as recently as Q3 2019.

Atwater Malick first reported a position in GSK in Q3 2019 and has held it in 2 quarters since. 748 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Atwater Malick held 12,925 shares of GSK worth $623K as of Q3 2026.
  • GSK was a new Atwater Malick position in Q3 2026.
  • GSK made up 0.14% of Atwater Malick's portfolio in Q3 2026, its #72 holding.
  • Atwater Malick first reported a position in GSK in Q3 2019 and has held it in 2 quarters since.
  • 748 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Atwater Malick's 13F filing for Q3 2026, filed 15 Oct 2026.